Synergistic Cannabidiol Therapy Systems
Legal Citation
Summary of the Inventive Concept
A novel approach integrating self-emulsifying cannabidiol formulations with advanced technologies such as AI, IoT, blockchain, and new materials to create personalized, real-time, and secure therapy systems.
Background and Problem Solved
The original patent disclosed self-emulsifying cannabidiol formulations, but these formulations lacked personalized treatment planning, real-time efficacy monitoring, and secure data management. The new inventive concept addresses these limitations by combining the original formulation with cutting-edge technologies.
Detailed Description of the Inventive Concept
The synergistic cannabidiol therapy system comprises a self-emulsifying cannabidiol composition, an AI-powered dosing algorithm, a blockchain-based patient data storage system, and IoT-enabled devices for real-time monitoring. The system enables personalized treatment planning, secure data management, and real-time efficacy monitoring. The AI-powered dosing algorithm optimizes treatment outcomes based on individual patient data, while the blockchain-based patient data storage system ensures secure and transparent data management. The IoT-enabled devices transmit data to a cloud-based analytics platform for analysis and feedback.
Novelty and Inventive Step
The new inventive concept introduces a synergistic combination of self-emulsifying cannabidiol formulations with AI, IoT, blockchain, and new materials, which is non-obvious and novel compared to the original patent. The integration of these technologies enables personalized, real-time, and secure therapy systems that were not possible with the original formulation alone.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept include wearable devices for transdermal delivery, smart packaging systems with NFC tags, and decentralized applications for cannabidiol treatment planning. Variations of the system can be implemented using different AI algorithms, IoT devices, or blockchain platforms.
Potential Commercial Applications and Market
The synergistic cannabidiol therapy system has significant commercial potential in the healthcare and wellness industries, particularly in the areas of personalized medicine, medical cannabis, and digital health. The system's ability to provide real-time efficacy monitoring, secure data management, and personalized treatment planning makes it an attractive solution for healthcare providers, patients, and pharmaceutical companies.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/107 |
| A | A61 | A61K9/4808 |
| A | A61 | A61K9/4825 |
| A | A61 | A61K31/05 |
| A | A61 | A61K47/10 |
| A | A61 | A61K47/14 |
| A | A61 | A61K47/22 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical formulation technologies, specifically cannabinoid delivery systems, drug composition design, and digital health technologies with expertise in emulsion science, pharmaceutical engineering, and medical device integration
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in pharmaceutical sciences, chemical engineering, or biomedical engineering, possessing knowledge of drug delivery systems, surfactant technologies, and emerging digital health platforms
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies with pharmaceutical formulations represents a predictable evolution of drug delivery systems. The combination of self-emulsifying cannabidiol compositions with AI, blockchain, and IoT technologies follows established patterns of technological convergence in personalized medicine. The technical elements disclosed in the PTD represent incremental improvements that leverage known technological capabilities to enhance drug delivery and patient monitoring.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,678 |
|---|---|
| Title | Self-emulsifying cannabidiol formulations |
| Assignee(s) | Benuvia Operations, LLC |